Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

Kennedy's disease leads to muscle weakness without a cure, but exercise and managing symptoms may help patients live a normal lifespan.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Different human traits like skin color and hair type vary between populations due to genetic adaptations to the environment.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Long COVID can cause anemia and iron issues, leading to fatigue and slow recovery, especially in men and severe cases.

The treatment improved menstrual flow and reduced ovarian cysts in mild to moderate PCOS cases.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Testosterone significantly affects urination differences between male and female mice.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Cinacalcet may help treat hereditary vitamin D resistant rickets safely.

A new syndrome, Teelwani Syndrome, combines features of two rare genetic disorders.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.